Atlanta Consulting Group Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$242K	–	133
2025 Q1	$242K	Buy	+500	New	+$242K	0.07%	107
2024 Q4	–	Sell	-1,769	Closed	-$823K	–	225
2024 Q3	$823K	Buy	1,769 +1,331	+304%	+$619K	0.2%	96
2024 Q2	$205K	Buy	+438	New	+$205K	0.04%	112